We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Deluxe
DLX
$1.19B
| $892K | 0.01% |
13,375
-46,454
| -78% | -$3.16M |
|
702
Essent Group
ESNT
$6.06B
| $889K | 0.01% |
33,420
+10,000
| +43% | +$253K |
|
703
Moody's
MCO
$81.7B
| $885K | 0.01% |
8,191
-690
| -8% | -$72.6K |
|
704
Stryker
SYK
$127B
| $877K | ﹤0.01% |
7,543
-738
| -9% | -$86K |
|
|
QGENF
705
DELISTED
QIAGEN NV
QGENF
| $871K | ﹤0.01% |
31,791
-1,217
| -4% | -$33.3K |
|
706
Sempra
SRE
$60.8B
| $868K | ﹤0.01% |
16,200
+434
| +3% | +$23.6K |
|
707
Tesla
TSLA
$1.24T
| $868K | ﹤0.01% |
63,900
-4,440
| -6% | -$64.1K |
|
708
Alliance Resource Partners
ARLP
$3.18B
| $867K | ﹤0.01% |
39,121
+8,970
| +30% | +$176K |
|
709
American Water Works
AWK
$26.3B
| $855K | ﹤0.01% |
11,446
+1,708
| +18% | +$134K |
|
710
PBF Energy
PBF
$7.29B
| $855K | ﹤0.01% |
37,822
-26,818
| -41% | -$603K |
|
|
BF
711
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $855K | ﹤0.01% |
10,014
| – | – |
|
|
ENLC
712
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $845K | ﹤0.01% |
50,483
+7,112
| +16% | +$115K |
|
|
ATHN
713
DELISTED
Athenahealth, Inc.
ATHN
| $845K | ﹤0.01% |
6,705
-860
| -11% | -$109K |
|
|
BMS
714
DELISTED
Bemis
BMS
| $837K | ﹤0.01% |
16,440
+14,820
| +915% | +$763K |
|
715
CNA Financial
CNA
$14.5B
| $836K | ﹤0.01% |
+24,320
| New | +$790K |
|
716
Aecom
ACM
$9.07B
| $827K | ﹤0.01% |
27,848
-22,879
| -45% | -$737K |
|
717
Dorman Products
DORM
$4.01B
| $823K | ﹤0.01% |
12,906
-217
| -2% | -$13.4K |
|
|
NUAN
718
DELISTED
Nuance Communications, Inc.
NUAN
| $820K | ﹤0.01% |
65,378
-9,855
| -13% | -$129K |
|
719
Darden Restaurants
DRI
$22.5B
| $817K | ﹤0.01% |
13,344
-2,276
| -15% | -$141K |
|
|
TCP
720
DELISTED
TC Pipelines LP
TCP
| $816K | ﹤0.01% |
14,310
-3,750
| -21% | -$203K |
|
721
Brown-Forman Class B
BF.B
$12B
| $813K | ﹤0.01% |
26,827
-820
| -3% | -$25.5K |
|
|
HA
722
DELISTED
Hawaiian Holdings, Inc.
HA
| $811K | ﹤0.01% |
16,698
| – | – |
|
723
Extra Space Storage
EXR
$31.2B
| $793K | ﹤0.01% |
9,999
+9,720
| +3,484% | +$820K |
|
|
FCE.A
724
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $789K | ﹤0.01% |
34,188
+13,499
| +65% | +$315K |
|
725
Vulcan Materials
VMC
$36.3B
| $787K | ﹤0.01% |
6,928
+17
| +0.2% | +$2K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.